Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fungal antigens are a heterogeneous group of molecules, including polysaccharides, proteins, and lipids, that constitute the structural and functional components of fungi. These antigens, such as beta-glucans, mannans, and chitin, are primarily located in the fungal cell wall and play vital roles in maintaining cellular integrity and mediating interactions with the host environment (Erwig & Gow, 2016). In the context of infectious diseases, they are the primary targets for the host's innate and adaptive immune responses, often triggering inflammatory cascades (Netea et al., 2015). Therapeutically, fungal antigens are exploited as targets for antifungal vaccines and monoclonal antibodies, which aim to enhance pathogen clearance or neutralize virulence factors (Edwards, 2012). Additionally, specific antigens like galactomannan and cryptococcal capsular polysaccharide serve as essential diagnostic biomarkers for identifying invasive mycoses in clinical settings (Odabasi et al., 2004). Drugs such as echinocandins work by inhibiting the synthesis of these antigenic components, specifically 1,3-beta-D-glucan, thereby disrupting the fungal cell wall (Perfect, 2017). Despite their utility, the high degree of variability in antigen expression across different fungal species and life stages poses a significant challenge for the development of universal antifungal therapies.
Inhibition of cell wall component synthesis, direct antibody-mediated neutralization, and induction of active immunity through vaccination (Perfect, 2017; Edwards, 2012).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal antigens.